Impact of RNase L overexpression on viral and cellular growth and death

Journal of Interferon and Cytokine Research

Volumn 18, Issue 11, 1998, Pages 953-961

  Zhou, Aimin ^a   Paranjape, Jayashree M ^a   Hassel, Bret A ^b   Nie, Huiqin ^a   Shah, Steven ^a   Galinski, Beverly ^c   Silverman, Robert H ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; INTERFERON; MONOCLONAL ANTIBODY; RIBONUCLEASE; RNA 18S; STAUROSPORINE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL DEATH; CELL GROWTH; CELL STRAIN 3T3; ENCEPHALOMYOCARDITIS VIRUS; GENE OVEREXPRESSION; IMMUNOMODULATION; MOUSE; NONHUMAN; PARAINFLUENZA VIRUS; PICORNAVIRUS; PRIORITY JOURNAL; PROMOTER REGION; VACCINIA VIRUS; VESICULAR STOMATITIS VIRUS; VIRUS INFECTION;

ANIMALIA; CYTOMEGALOVIRUS; ENCEPHALOMYOCARDITIS VIRUS; HUMAN PARAINFLUENZA VIRUS 3; MURINAE; PICORNAVIRIDAE; VACCINIA; VACCINIA VIRUS; VESICULAR STOMATITIS VIRUS;

EID: 0031673235     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1998.18.953     Document Type: Article

References (30)

1. STARK, G.R., KERR, I.M., WILLIAMS, B.R.G., SILVERMAN, R.H., and SCHREIBER, R.D. (1998). How cells respond to interferons. Annu. Rev. Biochem. 67, 227-264.
2. WILLIAMS, B.R.G., GOLGHER, R.R., BROWN, R.E., GILBERT, C.S., and KERR, I.M. (1979). Natural occurrence of 2-5A in interferon-treated EMC virus-infected L cells. Nature 282, 582-586.
3. nA) in interferon-treated cells. Nucleic Acids Res. 9, 1571-1581.
4. nA activity in interferon-treated encephalomyocarditis virus-infected cells. J. Virol. 46, 1051-1055.
5. CHEBATH, J., BENECH, P., REVEL, M., and VIGNERON, M. (1987). Constitutive expression of (2′-5) oligo A synthetase confers resistance to picornavirus infection. Nature 330, 587-588.
6. RYSIECKI, G., GEWERT, D.R., and WILLIAMS, B.R.G. (1989). Constitutive expression of a 2′,5′-oligoadenylate synthetase cDNA results in increased antiviral activity and growth suppression. J. Interferon Res. 9, 649-657.
7. COCCIA, E.M., ROMEO, G., NISSIM, A., MARZIALI, G., ALBERTINI, R., AFFABRIS, E., BATTISTINI, A., FIORUCCI, G., ORSATTI, R., ROSSI, G.B., and CHEBATH, J. (1990). A fulllength murine 2-5A synthetase cDNA transfected in NIH-3T3 cells impairs EMCV but not VSV replication. Virology 179, 228-233.
8. HASSEL, B.A., ZHOU, A., SOTOMAYOR, C., MARAN, A., and SILVERMAN, R.H. (1993). A dominant negative mutant of 2-5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon. EMBO J 12, 3297-3304.
9. ZHOU, A., PARANJAPE, J., BROWN, T.L., NIE, H., NAIK, S., DONG, B., CHANG, A., TRAPP, B., FAIRCHILD, R., COLMENARES, C., and SILVERMAN, R.H. (1997). Interferon action and apoptosis are defective in mice devoid of 2′,5′-oligoadenylate dependent RNase L. EMBO J. 16, 6355-6363.
10. CASTELLI, J.C., HASSEL, B.A., WOOD, K.A., LI, X.-L., AMEMIYA, K., DALAKAS, M.C., TORRENCE, P.F., and YOULE, R.J. (1997). A study of the interferon antiviral mechanism: apoptosis activation by the 2-5A system. J. Exp. Med. 186, 967-972.
11. CASTELLI, J.C., HASSEL, B.A., MARAN, A., PARANJAPE, J., HEWITT, J., LI, X., SILVERMAN, R.H., and YOULE, R.J. (1998). The role of 2′-5′ oligoadenylate-activated ribonuclease L in apoptosis. Cell Death Differ. 5, 313-320.
12. DIAZ-GUERRA, M., RIVAS, C., and ESTEBAN, M. (1997). Activation of the IFN-inducible enzyme RNase L causes apoptosis of animal cells. Virology 236, 354-363.
13. MAITRA, R.K., and SILVERMAN, R.H. (1998). Regulation of HIV replication by 2′,5′-oligoadenylate-dependent RNase L. J. Virol. 72, 1146-1152.
14. KITAJEWSKI, J., SCHNEIDER, R.J., SAFER, B., MUNEMITSU, S.M., SAMUEL, C.E., THIMMAPPAYA, B., and SHENK, T. (1986). Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2 alpha kinase. Cell 45, 195-200.
15. RICE, A.P., ROBERTS, W.K., and KERR, I.M. (1984). 2-5A accumulates to high levels in interferon-treated, vaccinia virus-infected cells in the absence of any inhibition of virus replication. J. Virol. 50, 220-228.
16. nA-dependent RNase. Eur. J. Biochem. 143, 165-174.
17. JACOBSEN, H., CZARNIECKI, C.W., KRAUSE, D., FRIEDMAN, R.M., and SILVERMAN, R.H. (1983). Interferon-induced synthesis of 2-5A-dependent RNase in mouse JLS-V9R cells. Virology 125, 496-501.
18. nA-dependent RNase in murine JLS-V9R cells during growth inhibition. Proc. Natl. Acad. Sci. USA 80, 4954-4958.
19. nA-dependent RNase levels during interferon treatment and cell differentiation. Eur. J. Biochem. 146, 611-618.
20. DIAZ-GUERRA, M., RIVAS, C., and ESTEBAN, M. (1997). Inducible expression of the 2-5A-synthetase/RNase L system results in inhibition of vaccinia virus replication. Virology 227, 220-228.
21. ZHOU, A., HASSEL, B.A., and SILVERMAN, R.H. (1993). Expression cloning of 2-5A-dependent RNase - a uniquely regulated mediator of interferon action. Cell 72, 743-765.
22. NOLAN-SORDEN, N.L., LESIAK, K., BAYARD, B., TORRENCE, P.F., and SILVERMAN, R.H. (1990). Photochemical crosslinking in oligonucleotide-protein complexes between a bromine-substituted 2-5A analogue and 2-5A-dependent RNase by ultraviolet lamp or laser. Anal. Biochem. 184, 298-304.
23. SILVERMAN, R.H., and KRAUSE, D. (1987). Interferon-regulated 2-5A and protein kinase systems. In Lymphokines and Interferons: Practical Approach. M.J. Clemens, A.G. Morris, and A.J.H. Gearing (eds.) Oxford: I.R.L. Press, pp. 149-193.
24. DONG, B., and SILVERMAN, R.H. (1995). 2-5A-dependent RNase molecules dimerize during activation by 2-5A. J. Biol. Chem. 270, 4133-4137.
25. GANGEMI, J.D., LAZDINS, J., DIETRICH, F.M., MATTER, A., PONCIONI, B., and HOCHKEPPEL, H.K. (1989). Antiviral activity of a novel recombinant human interferon-alpha B/D hybrid. J. Interferon Res. 9, 227-237.
26. HOVANESSIAN, A.G., WOOD, J., MEURS, E., and MONTAGNIER, L. (1979). Increased nuclease activity in cells treated with pppA2′p5′A2′p5′A. Proc. Natl. Acad. Sci. USA 76, 3261-3265.
27. KRAUSE, D., LESIAK, K., IMAI, J., SAWAI, H., TORRENCE, P.F., and SILVERMAN, R.H. (1986). Activation of 2-5A-dependent RNase by analogs of 2-5A (5′-O-triphosphoryladenylyl(2′->5′)adenylyl(2′-> 5′)adenosine) using 2′,5′-tetraadenylate (core)-cellulose. J. Biol. Chem. 261, 6836-6839.
28. DONG, B., XU, L., ZHOU, A., KASSEL, B.A., LEE, X., TORRENCE, P.F., and SILVERMAN, R.H. (1994). Intrinsic molecular activities of the interferon-induced 2-4A-dependent RNAse. J. Biol. Chem. 269, 14153-14158.
29. SILVERMAN, R.H., JUNG, D.D., NOLAN-SORDEN, N.L., DIEFFENBACH, C.W., KEDAR, V.P., and SENGUPTA, D. (1988). Purification and analysis of murine 2-5A-dependent RNase. J. Biol. Chem. 263, 7336-7341.
30. STARK, G.R., DOWER, W.J., SCHIMKE, R.T., BROWN, R.E., and KERR, I.M. (1979). 2-5A synthetase: assay, distribution and variation with growth or hormone status. Nature 278, 471-473.